Celldex Therapeutics, Inc. (CLDX)

Nasdaq: CLDX · In Vitro & In Vivo Diagnostic Substances · Hampton, NJ · filing with the SEC since 1995

Grade5.1

◀ Past 3.8● Present 6.0▶ Future 5.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 25, 2026	Feb 27, 2025	Feb 26, 2024	Feb 28, 2023	Feb 28, 2022	Mar 29, 2021	Mar 26, 2020	Mar 7, 2019	Mar 7, 2018	Mar 14, 2017
Revenue	1,545	7,020	6,883	2,357	4,651	7,418	3,573	9,538	12,743	6,786
Cost of revenue	200	200	300	100	100	200	100	700	700	1,600
Research and development	245,074	163,550	118,011	82,258	53,311	42,534	42,672	66,449	96,171	102,726
General and administrative	43,838	38,548	30,914	27,195	20,488	14,456	15,426	19,269	25,003	35,979
Total costs and expenses	288,912	202,098	161,425	117,591	75,894	70,772	58,604	165,974	134,270	139,702
Operating income	-287,367	-195,078	-154,542	-115,234	-71,243	-63,354	-55,031	-156,436	-121,527	-132,916
Income before income taxes	-258,757	-157,863	-141,429	-112,325	-70,738	-60,947	-50,878	-151,949	-117,313	-128,530
Income tax expense	0	0	0	·	-227	-1,167	·	-765	-24,282	·
Net income	-258,757	-157,863	-141,429	·	·	·	·	·	·	·
Net income to common shareholders	-258,757	-157,863	-141,429	-112,325	-70,511	-59,780	-50,878	-151,184	-93,031	-128,530
Earnings per share, basic	-3.90	-2.45	-2.92	-2.40	-1.64	-2.02	-3.51	·	·	·
Earnings per share, diluted	-3.90	-2.45	-2.92	-2.40	-1.64	-2.02	-3.51	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-2.02	-3.51	-14.48	-10.86^r	-18.99^r
Weighted average shares, basic	66,422,000	64,395,000^r	48,449,000^r	46,888	42,870	29,640	14,507	·	·	·
Weighted average shares, diluted	66,422,000	64,395,000^r	48,449,000^r	46,888,000^b	42,870,000^b	29,640,000^b	14,507,000^b	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	29,640	14,507^r	10,442^r	8,570,000^r	6,769,000^r

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton CLDX · research, not advice